ALMKT:EPA
Mauna Kea Technologies SA
0,095 €
arrow_upward
+0,11%(+0,00010) 1 d.
12. 11., 13:00:53 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre ALMKT…
Otvoriť
0,10 €
Vysoká
0,10 €
Nízka
0,09 €
Trh. kap.
19,46 mil.
Priem. obj.
545,11 tis.
Objem
160,98 tis.
Pomer cena/zárobky
0,81
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
56
Otvoriť
0,10 €
Vysoká
0,10 €
Nízka
0,09 €
Trh. kap.
19,46 mil.
Priem. obj.
545,11 tis.
Objem
160,98 tis.
Pomer cena/zárobky
0,81
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
56
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
TradingView
·
pred 1 hodinou
Stock Market Today: Nvidia Rout Sinks Nasdaq, S&P 500 Futures as Board Weighs Jensen Huang’s Future — CRWV, TTEK, FNV in Focus
Yahoo Finance
·
pred 1 hodinou
What Invesco S&P 500 Equal Weight ETF (RSP) Bought: Moderna Leads on Nov. 10
BigGo Finance
·
pred 1 hodinou
S&P 500 Has Risen After All 19 Midterm Elections Since 1950, Morgan Stanley Data Show
FXStreet
·
pred 4 hodinami
S&P 500: Tech rally offsets post‑CPI selloff – Deutsche Bank
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Informácie o subjekte Mauna Kea Technologies SA
Generálny riaditeľSacha Loiseau
Zamestnanci56
Dátum založenia2000
Hlavné sídlo-
OdvetvieHealth Care
Odvetvie-